http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108721319-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 |
filingDate | 2018-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2020-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2020-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-108721319-B |
titleOfInvention | Application of agent for inhibiting circ _ CLASP2 in preparation of nasopharyngeal carcinoma treatment preparation and preparation |
abstract | The invention discloses application of a circ _ CLASP2 inhibiting reagent in preparation of a nasopharyngeal carcinoma treatment preparation and the preparation. Research proves that the proliferation and invasion metastasis of nasopharyngeal carcinoma cells can be inhibited by inhibiting circ _ CLASP2 in the nasopharyngeal carcinoma cells. Therefore, the circ _ CLASP2 inhibitor is used for treating nasopharyngeal carcinoma, and has profound clinical significance and important popularization and application prospects. |
priorityDate | 2018-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 30.